[EN] MULTIMEDIATOR DPP4 AND FAP INHIBITORS, AND USES RELATED THERETO<br/>[FR] INHIBITEURS DE DPP4 ET DE FAP MULTIMÉDIATEURS, ET UTILISATIONS ASSOCIÉES
申请人:TUFTS COLLEGE
公开号:WO2017189569A1
公开(公告)日:2017-11-02
Disclosed is a pharmaceutical preparation comprising a multimediator inhibitor agent that both inhibits DPP4 enzymatic activity with a Ki of 100 nM or less and inhibits Fibroblast Activation Protein (FAP) enzymatic activity with a Ki of 100 nM or less, which multimediator is orally active and is formulated for oral administration at a dosing frequency of 24 hours or greater.